Steward Partners Investment Advisory, LLC Synthetic Biologics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	BUY	$4.9 - $6.6 $700 - $943	143 New	143 $0
Q4 2018 Jan 15, 2019	SELL	$5.2 - $26.8 $743 - $3,832	-143 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$20.4 - $80.5 $2,917 - $11,511	143 New	143 $0

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.